Skip to main content
curacle co., ltd. logo

curacle co., ltd. — Investor Relations & Filings

Ticker · 365270 ISIN · KR7365270008 KO Professional, scientific and technical activities
Open in API
Filings indexed 203 across all filing types
Latest filing 2021-07-16 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 365270

About curacle co., ltd.

http://www.curacle.com/eng/main/

Curacle Co., Ltd. is a clinical-stage biopharmaceutical company focused on the research and development of innovative drugs for intractable vascular diseases. The company's core platform technology centers on developing highly effective protectors against endothelial dysfunction, a key factor in various age-related and vascular conditions. Its development pipeline includes novel treatments targeting significant unmet medical needs, with a particular focus on conditions such as Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration (wet AMD), diabetes, and stroke. Curacle aims to create differentiated therapies through innovative targets and treatment concepts, including the development of orally administered medications for complex eye diseases.

Recent filings

Filing Released Lang Actions
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the final results of a public offering, including subscription and allocation data for institutional and retail investors. According to the provided filing definitions, this type of regulatory filing regarding share issuance and capital changes is classified as 'SHA' (Share Issue/Capital Change).
2021-07-16 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of public offering terms (공모가액 확정) for Curacle Co., Ltd. (주식회사 큐라클), including share quantities, pricing, and underwriting details. This is a formal regulatory filing required for an IPO or capital raise, which falls under the 'Regulatory Filings' category as it is a primary legal disclosure document.
2021-07-12 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 95% confidence The document is a 'Correction Report' (정정신고서) for a Securities Registration Statement (투자설명서) filed by Curacle Co., Ltd. It details changes to the public offering price (from a range of 20,000-25,000 KRW to a fixed 25,000 KRW) and associated adjustments to the offering structure, underwriting details, and share allocation. This is a formal regulatory filing related to a capital raising event (IPO/Public Offering). Since it is a detailed regulatory document regarding the terms of a capital issuance rather than a simple announcement of a report, it falls under the 'Capital/Financing Update' category.
2021-07-12 Korean
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement' (투자설명서) for Curacle Co., Ltd. (주식회사 큐라클) dated July 7, 2021. It contains detailed information regarding a public offering of shares, including offering price, subscription period, investment risks, and business overview. This is a formal regulatory filing required for public offerings in South Korea, which falls under the category of Proxy Solicitation & Information Statement (PSI) or, more broadly, a regulatory filing document used to inform potential investors during a capital raise.
2021-07-07 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Amendment to Securities Registration Statement for Equity Securities) filed by Curacle. It details specific amendments to the initial registration statement, including updates to investment risk factors, management information, and valuation methodologies for an upcoming public offering. This type of regulatory filing is a standard part of the IPO process in South Korea and falls under the category of Regulatory Filings (RNS) as it does not fit into the specific categories like 10-K or IR.
2021-07-02 Korean
증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed by Curacle Co., Ltd. with the Financial Services Commission (FSC) in South Korea. It contains detailed information regarding the issuance of securities, investment risks, business overview, and financial disclosures required for a public offering. This is a formal regulatory filing document used for capital raising, which falls under the category of Regulatory Filings (RNS) as it is a primary legal disclosure document for securities registration.
2021-06-15 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.